Since GIP receptors are downregulated/desensitised during obesity/T2DM (Lynn et al. 2001, Meier & Nauck 2010), stabilised variants of GLP-1 have served as a template for production of incretin mimetics. This evidence concerns the gene GCG and obesity disorder.